Jim Cramer Shares Key Caveat For Novo Nordisk (NVO)’s Weight Loss Pill
We recently published 10 Stocks on Jim Cramer’s Radar. Novo Nordisk A/S (NYSE:NVO) is one of the stocks on Jim Cramer's radar. Danish pharmaceutical firm Novo Nordisk A/S (NYSE:NVO) scored a major win earlier this month after it secured the Food and Drug Administration’s (FDA) approval for its weight loss pill. The approval made the Wegovy pill the first of its kind, and it led to the firm’s shares closing 7.30% higher. The approval marked a key win for Novo Nordisk A/S (NYSE:NVO) as the firm has reporte ...